PERSPECTA

News from every angle

← Back to headlines

CytomX Therapeutics stock rises amid colorectal cancer treatment progress

CytomX Therapeutics, Inc. (CTMX) is highlighted as a top healthcare penny stock due to its progress in colorectal cancer treatment.

14 Apr, 09:56 — 14 Apr, 09:56
PostShare

Sources

Showing 1 of 1 sources
YahooMostly Factual2d ago

CytomX Therapeutics, Inc. (CTMX) A Top Healthcare Penny Stock Amid Colorectal Cancer Treatment Progress

Read full article →

Related Stories

Philippines Records, Forecasts 'Danger' Heat Indices

just now

Philippines Forecasts 'Danger' Level Heat Indices for Multiple Days

just now

Baby Falls from First-Floor Window in Verviers, Belgium

13m ago

FDA Considers Easing Peptide Restrictions Amid RFK Jr.'s Advocacy, Experts Warn of Risks

14m ago